413 related articles for article (PubMed ID: 34899188)
21. Pharmacological targeting of microglia dynamics in Alzheimer's disease: Preclinical and clinical evidence.
Yousefizadeh A; Piccioni G; Saidi A; Triaca V; Mango D; Nisticò R
Pharmacol Res; 2022 Oct; 184():106404. PubMed ID: 35988869
[TBL] [Abstract][Full Text] [Related]
22. Non-Coding RNA in Microglia Activation and Neuroinflammation in Alzheimer's Disease.
He C; Li Z; Yang M; Yu W; Luo R; Zhou J; He J; Chen Q; Song Z; Cheng S
J Inflamm Res; 2023; 16():4165-4211. PubMed ID: 37753266
[TBL] [Abstract][Full Text] [Related]
23. Innate immunity in Alzheimer's disease: a complex affair.
Guillot-Sestier MV; Town T
CNS Neurol Disord Drug Targets; 2013 Aug; 12(5):593-607. PubMed ID: 23574177
[TBL] [Abstract][Full Text] [Related]
24. Microglial activation correlates in vivo with both tau and amyloid in Alzheimer's disease.
Dani M; Wood M; Mizoguchi R; Fan Z; Walker Z; Morgan R; Hinz R; Biju M; Kuruvilla T; Brooks DJ; Edison P
Brain; 2018 Sep; 141(9):2740-2754. PubMed ID: 30052812
[TBL] [Abstract][Full Text] [Related]
25. Role of TREM2 in Alzheimer's Disease and its Consequences on β- Amyloid, Tau and Neurofibrillary Tangles.
Singh AK; Mishra G; Maurya A; Awasthi R; Kumari K; Thakur A; Rai A; Rai GK; Sharma B; Kulkarni GT; Singh SK
Curr Alzheimer Res; 2019; 16(13):1216-1229. PubMed ID: 31481003
[TBL] [Abstract][Full Text] [Related]
26. Microglia in Alzheimer's Disease in the Context of Tau Pathology.
Perea JR; Bolós M; Avila J
Biomolecules; 2020 Oct; 10(10):. PubMed ID: 33066368
[TBL] [Abstract][Full Text] [Related]
27. Drug Development for Alzheimer's Disease: Microglia Induced Neuroinflammation as a Target?
Dong Y; Li X; Cheng J; Hou L
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30696107
[TBL] [Abstract][Full Text] [Related]
28. The engagement of microglia in tau-targeted immunotherapy in Alzheimer's disease.
Palova D; Turic Csokova N; Markova K; Kontsekova E; Kovacech B; Zilkova M
Gen Physiol Biophys; 2021 Nov; 40(6):463-478. PubMed ID: 34897021
[TBL] [Abstract][Full Text] [Related]
29. Galectin-3: a key player in microglia-mediated neuroinflammation and Alzheimer's disease.
Tan Y; Zheng Y; Xu D; Sun Z; Yang H; Yin Q
Cell Biosci; 2021 Apr; 11(1):78. PubMed ID: 33906678
[TBL] [Abstract][Full Text] [Related]
30. Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease.
Cai Z; Hussain MD; Yan LJ
Int J Neurosci; 2014 May; 124(5):307-21. PubMed ID: 23930978
[TBL] [Abstract][Full Text] [Related]
31. Microglial Activation in the Retina of a Triple-Transgenic Alzheimer's Disease Mouse Model (3xTg-AD).
Salobrar-García E; Rodrigues-Neves AC; Ramírez AI; de Hoz R; Fernández-Albarral JA; López-Cuenca I; Ramírez JM; Ambrósio AF; Salazar JJ
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012676
[TBL] [Abstract][Full Text] [Related]
32. Neuroinflammatory responses in Alzheimer's disease.
Dansokho C; Heneka MT
J Neural Transm (Vienna); 2018 May; 125(5):771-779. PubMed ID: 29273951
[TBL] [Abstract][Full Text] [Related]
33. Amyloid β and Tau Alzheimer's disease related pathology is reduced by Toll-like receptor 9 stimulation.
Scholtzova H; Chianchiano P; Pan J; Sun Y; Goñi F; Mehta PD; Wisniewski T
Acta Neuropathol Commun; 2014 Sep; 2():101. PubMed ID: 25178404
[TBL] [Abstract][Full Text] [Related]
34. Microglia as a cellular target of diclofenac therapy in Alzheimer's disease.
Stopschinski BE; Weideman RA; McMahan D; Jacob DA; Little BB; Chiang HS; Saez Calveras N; Stuve O
Ther Adv Neurol Disord; 2023; 16():17562864231156674. PubMed ID: 36875711
[TBL] [Abstract][Full Text] [Related]
35. Emerging roles of microglial cathepsins in neurodegenerative disease.
Lowry JR; Klegeris A
Brain Res Bull; 2018 May; 139():144-156. PubMed ID: 29454581
[TBL] [Abstract][Full Text] [Related]
36. Microglia as a potential bridge between the amyloid beta-peptide and tau.
Kitazawa M; Yamasaki TR; LaFerla FM
Ann N Y Acad Sci; 2004 Dec; 1035():85-103. PubMed ID: 15681802
[TBL] [Abstract][Full Text] [Related]
37. Microglia in Alzheimer's disease: pathogenesis, mechanisms, and therapeutic potentials.
Miao J; Ma H; Yang Y; Liao Y; Lin C; Zheng J; Yu M; Lan J
Front Aging Neurosci; 2023; 15():1201982. PubMed ID: 37396657
[TBL] [Abstract][Full Text] [Related]
38. Progression of neurofibrillary changes and PHF-tau in end-stage Alzheimer's disease is different from plaque and cortical microglial pathology.
Thal DR; Arendt T; Waldmann G; Holzer M; Zedlick D; Rüb U; Schober R
Neurobiol Aging; 1998; 19(6):517-25. PubMed ID: 10192210
[TBL] [Abstract][Full Text] [Related]
39. Lipid metabolism transcriptomics of murine microglia in Alzheimer's disease and neuroinflammation.
Shippy DC; Ulland TK
Sci Rep; 2023 Sep; 13(1):14800. PubMed ID: 37684405
[TBL] [Abstract][Full Text] [Related]
40. Hypoxia-Induced Neuroinflammation in Alzheimer's Disease: Potential Neuroprotective Effects of
Hambali A; Kumar J; Hashim NFM; Maniam S; Mehat MZ; Cheema MS; Mustapha M; Adenan MI; Stanslas J; Hamid HA
Front Physiol; 2021; 12():712317. PubMed ID: 34721056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
